SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.820
0.00 (0.00%)
Jan 2, 2025, 12:38 PM EST - Market open
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $35.26 million as of January 2, 2025. Its market cap has decreased by -8.74% in one year.
Market Cap
35.26M
Enterprise Value
9.14M
1-Year Change
-8.74%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $35.26M, a decrease of -73.04%. That is a compound annual growth rate of -28.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |